Amanda studied mathematics and statistics as an undergraduate and in 2009 she was awarded a PhD from the University of Strathclyde, where she developed mathematical infectious disease models to investigate the impact of vaccination on pneumococcal disease in Scotland. This work was funded by Health Protection Scotland and through this connection Amanda joined the blood borne viruses and sexually transmitted infection (BBVSTI) team, and became involved in the Hepatitis C Action Plan for Scotland, now known as the Sexual Health and Blood Borne Virus Framework.
During her time at HPS, Amanda became skilled in cost-effectiveness analysis, and worked with colleagues to estimate the current and future economic burden of hepatitis C in Scotland, which was a key piece of work carried out during Phase I of the Action Plan. As well as research based projects, Amanda also has an interest in communicable disease surveillance, and works with colleagues at GCU and Health Protection Scotland on the development of the national hepatitis B & C test databases.
She is currently investigating the reinfection of hepatitis C among people who have been successfully treated in Scotland using data from the hepatitis C test database. This stream of work also includes the use of record linkage methodology to investigate the morbidity and mortality associated with individuals who are infected with hepatitis B and/or hepatitis C.
In 2011, Amanda worked on a variety of hepatitis C related projects within the Centre for Population Health at the Burnet Institute in Melbourne, Australia. The collaboration continues, and she is currently working with colleagues at the Burnet Institute to investigate the mortality & survival among a cohort of people who inject drugs.